Medical Center OK!Clinic+LLC International Institute of Clinical Research

Kyiv 2091

0 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Primary Biliary Cholangitis, Primary Immune Thrombocytopenia, Ulcerative Colitis

Studies at this site

• A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia — Completed
• RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) — Completed
• Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307) — Stopped early
• Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306) — Stopped early